New Haven, Connecticut 06510

  • Parkinsonian Syndrome


This study involves study participants who have been clinically diagnosed with parkinsonian syndrome or who are at-risk for parkinsonian syndrome, have a family history of parkinsonian syndrome or exposure to environmental toxins potentially associated with parkinsonian syndrome. Participants will have brain imaging to assess dopamine transporter density. The imaging data coupled with family history and environmental exposure data may provide important information about potential risk factors for parkinsonian syndrome.

Study summary:

The brain imaging is conducted at the Institute for Neurodegenerative Disorders in New Haven, Connecticut. The imaging procedure occurs over a two day period. On the first day participants are injected with [123I]ß CIT, an investigational radioactive material that localizes in the brain. Study participants will also have a thorough neurologic examination and standard neuropsychological testing, including testing of memory, concentration, abstraction and visual spatial functions. Twenty-four hours later study participants return to the Institute for Neurodegenerative Disorders where an investigational scanning procedure will be used to obtain SPECT (single photon emission computed tomography) images of the brain. Participants may be contacted to repeat these procedures every 12 to 18 months.


Inclusion Criteria: - 22 years or older - A clinical diagnosis of Parkinson's disease (PD), positive family history of PD and/or potential exposure to environmental toxins - Normal screening laboratory studies Exclusion Criteria: - Pregnancy - Psychiatric disease other than history of depression - Significant medical disease including abnormalities on screening



Primary Contact:

Principal Investigator
Kenneth L. Marek, MD
President and Senior Scientist

Susan Mendick, MPH
Phone: 203-401-4300

Backup Contact:


Location Contact:

New Haven, Connecticut 06510
United States

Barbara Fussell, RN
Phone: 203-401-4300

Site Status: Recruiting

Data Source:

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.